DE2809618A1 - Neues therapeutisches praeparat und verfahren zu dessen herstellung - Google Patents

Neues therapeutisches praeparat und verfahren zu dessen herstellung

Info

Publication number
DE2809618A1
DE2809618A1 DE19782809618 DE2809618A DE2809618A1 DE 2809618 A1 DE2809618 A1 DE 2809618A1 DE 19782809618 DE19782809618 DE 19782809618 DE 2809618 A DE2809618 A DE 2809618A DE 2809618 A1 DE2809618 A1 DE 2809618A1
Authority
DE
Germany
Prior art keywords
salts
heparin
formula
compounds
isopropyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19782809618
Other languages
German (de)
English (en)
Inventor
Nichtnennung Beantragt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CA267,029A priority Critical patent/CA1079194A/fr
Application filed by Sandoz AG filed Critical Sandoz AG
Priority to DE19782809618 priority patent/DE2809618A1/de
Priority to CH184079A priority patent/CH639271A5/de
Priority to GB7907393A priority patent/GB2015338B/en
Priority to CY1298A priority patent/CY1298A/xx
Priority to PH22245A priority patent/PH16800A/en
Priority to NL7901702A priority patent/NL7901702A/xx
Priority to BE0/193847A priority patent/BE874626R/fr
Priority to JP2460879A priority patent/JPS54126736A/ja
Priority to NZ789817A priority patent/NZ189817A/xx
Priority to FR7905752A priority patent/FR2419070A2/fr
Priority to ZA791032A priority patent/ZA791032B/xx
Priority to IE701/79A priority patent/IE48192B1/en
Publication of DE2809618A1 publication Critical patent/DE2809618A1/de
Priority to SG49185A priority patent/SG49185G/en
Priority to KE3548A priority patent/KE3548A/xx
Priority to HK810/85A priority patent/HK81085A/xx
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
DE19782809618 1975-12-04 1978-03-06 Neues therapeutisches praeparat und verfahren zu dessen herstellung Withdrawn DE2809618A1 (de)

Priority Applications (16)

Application Number Priority Date Filing Date Title
CA267,029A CA1079194A (fr) 1975-12-04 1976-12-02 Compose pharmaceutique pour le traitement prophylactique des thromboses
DE19782809618 DE2809618A1 (de) 1978-03-06 1978-03-06 Neues therapeutisches praeparat und verfahren zu dessen herstellung
CH184079A CH639271A5 (de) 1978-03-06 1979-02-23 Therapeutisches praeparat und verfahren zu dessen herstellung.
GB7907393A GB2015338B (en) 1978-03-06 1979-03-02 Pharmaceutical compositions containg ergot alkaloids and heparing
CY1298A CY1298A (en) 1978-03-06 1979-03-02 Pharmaceutical compositions containing ergot alkaloids and heparin
PH22245A PH16800A (en) 1978-03-06 1979-03-02 Pharmaceutical compositions containing dihydroergotamine and heparin
NL7901702A NL7901702A (nl) 1978-03-06 1979-03-02 Werkwijze voor het bereiden van een geneesmiddel.
BE0/193847A BE874626R (fr) 1978-03-06 1979-03-05 Nouvelle association medicamenteuse
JP2460879A JPS54126736A (en) 1978-03-06 1979-03-05 Improvement of organic compound
NZ789817A NZ189817A (en) 1978-03-06 1979-03-05 Certain synergistic anti-thrombotic compositions utilizing ergot peptide alkaloid/heparin combinations
FR7905752A FR2419070A2 (fr) 1978-03-06 1979-03-06 Nouvelle association medicamenteuse
ZA791032A ZA791032B (en) 1978-03-06 1979-03-06 Pharmaceutical compositions
IE701/79A IE48192B1 (en) 1978-03-06 1979-08-08 Pharmaceutical compositions containing an ergot alkaloid and heparin
SG49185A SG49185G (en) 1978-03-06 1985-06-24 Pharmaceutical compositions containing an ergot alkaloid and heparin
KE3548A KE3548A (en) 1978-03-06 1985-07-11 Pharmaceutical compositions containing an ergot alkaloid and heparin
HK810/85A HK81085A (en) 1978-03-06 1985-10-17 Pharmaceutical compositions containing an ergot alkaloid and heparin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782809618 DE2809618A1 (de) 1978-03-06 1978-03-06 Neues therapeutisches praeparat und verfahren zu dessen herstellung

Publications (1)

Publication Number Publication Date
DE2809618A1 true DE2809618A1 (de) 1979-09-20

Family

ID=6033695

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782809618 Withdrawn DE2809618A1 (de) 1975-12-04 1978-03-06 Neues therapeutisches praeparat und verfahren zu dessen herstellung

Country Status (15)

Country Link
JP (1) JPS54126736A (fr)
BE (1) BE874626R (fr)
CH (1) CH639271A5 (fr)
CY (1) CY1298A (fr)
DE (1) DE2809618A1 (fr)
FR (1) FR2419070A2 (fr)
GB (1) GB2015338B (fr)
HK (1) HK81085A (fr)
IE (1) IE48192B1 (fr)
KE (1) KE3548A (fr)
NL (1) NL7901702A (fr)
NZ (1) NZ189817A (fr)
PH (1) PH16800A (fr)
SG (1) SG49185G (fr)
ZA (1) ZA791032B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3343818A1 (de) * 1982-12-10 1984-06-14 Sandoz-Patent-GmbH, 7850 Lörrach Neues therapeutisches praeparat enthaltend hydrierte ergotalkaloide und heparin
AT382514B (de) * 1982-12-10 1987-03-10 Sandoz Ag Verfahren zur herstellung eines therapeutischen praeparates, enthaltend hydrierte ergotalkaloide und heparin

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2945636A1 (de) * 1979-11-12 1981-05-21 Sandoz-Patent-GmbH, 7850 Lörrach Stabile loesungen von hydrierten ergotalkaloiden bzw. ihren salzen und heparin bzw. seinen salzen sowie verfahren zu deren herstellung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE441142B (sv) * 1975-12-04 1985-09-16 Sandoz Ag Forfarande for framstellning av ett terapeutiskt preparat med antitrombotiska egenskaper

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3343818A1 (de) * 1982-12-10 1984-06-14 Sandoz-Patent-GmbH, 7850 Lörrach Neues therapeutisches praeparat enthaltend hydrierte ergotalkaloide und heparin
AT382514B (de) * 1982-12-10 1987-03-10 Sandoz Ag Verfahren zur herstellung eines therapeutischen praeparates, enthaltend hydrierte ergotalkaloide und heparin

Also Published As

Publication number Publication date
ZA791032B (en) 1980-10-29
GB2015338B (en) 1982-08-18
FR2419070B1 (fr) 1982-08-06
JPS54126736A (en) 1979-10-02
SG49185G (en) 1986-01-17
IE790701L (en) 1979-09-06
CH639271A5 (de) 1983-11-15
NZ189817A (en) 1981-04-24
PH16800A (en) 1984-03-01
KE3548A (en) 1985-08-02
GB2015338A (en) 1979-09-12
HK81085A (en) 1985-10-25
CY1298A (en) 1985-10-18
NL7901702A (nl) 1979-09-10
IE48192B1 (en) 1984-10-31
FR2419070A2 (fr) 1979-10-05
BE874626R (fr) 1979-09-05

Similar Documents

Publication Publication Date Title
DE69223624T2 (de) Taxan-derivate enthaltende arzneimittel
DE69328192T4 (de) Injizierbare Arzneizubereitungen enthaltend Taxanderivate
DE69334073T2 (de) Alkalimetall-8,9-Dehydroestronsulfatester
DE69409969T2 (de) Salze der mehrfach ungesättigten fettsäuren und diese enthaltende pharmazeutischen zusammensetzungen
DE3042332C2 (fr)
DE3318649A1 (de) Zweiphasenformulierung
DE2721171A1 (de) Neues vincaminsalz, seine herstellung und es enthaltende pharmazeutische zubereitungen
DE2948869C2 (fr)
CH645805A5 (de) Suppositorien mit einem gehalt an einer verbindung mit bronchodilatatorischer aktivitaet.
DE4038385C2 (de) Sitosterol und seine Glykoside mit verbesserter Bioverfügbarkeit
DE2729824A1 (de) Pharmazeutische zusammensetzungen mit organischen montmorillonit-derivaten und ihre herstellung
DE69307895T2 (de) Therapeutische verwendung von phosphoryl-l-serin-n-acyl-sphingosin
DE3119510C2 (fr)
DE2719690A1 (de) Stabilisierte prostaglandinzubereitung und verfahren zur herstellung derselben
DE2809618A1 (de) Neues therapeutisches praeparat und verfahren zu dessen herstellung
DE2251559C2 (de) 5,6-Dihydro-pyrrolo[3,4-b]pyridinderivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen
DE69001513T2 (de) Polyprenylverbindung enthaltende Zusammensetzung für weiche Kapseln.
EP1021198A1 (fr) Preparations de flavonolignan, notamment preparations a base de silymarine
DE2554533A1 (de) Neue therapeutische mischung und verfahren zu deren herstellung
DE2625403A1 (de) Neue therapeutische mischung und verfahren zu deren herstellung
AT362051B (de) Verfahren zur herstellung von injektions- praeparaten
EP0240874B1 (fr) Préparation de l'hymécromone à résorption élevée et son procédé de préparation
DD267664A5 (de) Verfahren zur herstellung von kamillenoelen mit hohem gehalt an natuerlichen cis- und trans-spiroethern
DE2129422C3 (de) 4-Acetoxy-4'-sulfoxy-diphenyl-(pyridyl-2)-methan
DE3044736A1 (de) Antitumor-mittel, verfahren zu deren herstellung und dosierungsformen

Legal Events

Date Code Title Description
AF Is addition to no.

Ref country code: DE

Ref document number: 2554533

Format of ref document f/p: P

8130 Withdrawal